Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.
NCT ID: NCT03485755
Last Updated: 2019-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2018-03-12
2018-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Microbiome Research and Development for Overcoming Pediatric Diseases
NCT06812091
Clinical Study of Novel Probiotic Microbial Compositeâ„¢ to Treat Undernourished Young Children
NCT03150927
Probiotic on Atopic Dermatitis in Infant
NCT05286047
A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis
NCT04662619
Tolerability and Functional Assessment of a Novel Children's Synbiotic
NCT04534036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children
Children 8-10 years of age
No interventions assigned to this group
Biological Mothers
Biological mothers of children now ages 8-10 years of age
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All subjects are to have normal healthy skin and no presence of pre-existing or dormant dermatologic skin conditions;
* Willing to use only the provided cleansing product during the washout time period;
* Willing to refrain from topical product use on the skin for the duration of the study. Topical products that should not be used include moisturizers, lotions, sunscreens, oils, tanners;
* Willing to refrain from swimming, using hot tubs, excessive sun exposure or tanning beds during the course of this study;
Exclusion Criteria
8 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Consumer Inc. (J&JCI)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce L Moskovitz, MD
Role: PRINCIPAL_INVESTIGATOR
Bruce L Moskovitz MD - private consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consumer Experience Center
Skillman, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCSSKA000104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.